相关实验视频

Updated: May 28, 2025

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

利用Mn2+离子和抗瘤:一种强大的凝,用于增强瘤免疫治疗

Tong Guan^1,2, Ziwei Chen^1,2, Xin Wang^1,3

¹New Cornerstone Science Laboratory, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing 100190, China.

Journal of the American Chemical Society

|February 14, 2025

概括

这项研究引入了一种新型的化水凝,可提供离子和抗PD-1抗体. 这种双作用免疫疗法平台有效地抑制瘤生长,并通过增强免疫反应来预防复发.

科学领域:

生物医学工程生物医学工程
免疫学免疫学免疫学
材料科学材料科学材料科学

背景情况:

免疫疗法提供持久的抗瘤效果,但面临系统毒性和药物保留不良的挑战.
开发局部传递系统对于提高癌症免疫疗法的有效性和安全性至关重要.

研究的目的:

为增强癌症免疫疗法设计一种双功能的抗瘤类水凝.
为了研究离子 (Mn2+) 在基凝中作为免疫调节器载体的潜力.

主要方法:

一种双重功能抗瘤 (N-Pep) 被设计成通过与Mn2+离子 (N-Pep-Mn凝) 的协调自组装成水凝.
液凝装满了针对持续释放的抗编程死亡-1抗体 (αPD-1).
在体内评估了N-Pep-Mn凝对免疫细胞和瘤生长的影响.

主要成果:

该N-Pep-Mn凝促进了Mn2+和αPD-1的持续释放,增强了树突细胞激活,M2巨细胞极化和T细胞透.
内和全身免疫反应得到有效增强,导致显著的瘤生长抑制.
治疗诱导了强大的免疫记忆,提供了对瘤复发的保护.

结论:

2+离子协调抗瘤酸液凝代表了癌症免疫治疗的有前途的先进平台.
这种新的水凝系统克服了全身传递的局限性,改善了治疗结果和免疫记忆.

更多相关视频

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.